Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC — Stella

Recruiting

Back to Mpox (Monkeypox) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

Democratic Republic of the Congo

Boende Hôpital Général de Référence, Boende, Boende, La Tshuapa

Key details

Phase

Large-scale testing

Sponsor

Jean-Pierre Van geertruyden

Collaborators

Ace Africa, PENTA Foundation

Enrollment target

~344 participants

Started

May 2025

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

4 Months – 24 Months

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov